21 Participants Needed

CARE Program for Postpartum Mental Health

(PMAD-CARE Trial)

OJ
AZ
Overseen ByAmanda Zayde, Psy.D.
Age: 18+
Sex: Female
Trial Phase: Academic
Sponsor: Montefiore Medical Center
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Approved in 1 JurisdictionThis treatment is already approved in other countries

Trial Summary

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications. It seems focused on group therapy, so you may not need to change your medication routine, but it's best to confirm with the trial organizers.

What data supports the effectiveness of the CARE Parenting Program treatment for postpartum mental health?

The CARE Parenting Program may be effective because similar mentalization-based programs have been positively evaluated for improving parental skills and reducing stress in parents with mental illness, as seen in the Lighthouse Parenting Program study.12345

How is the CARE Parenting Program treatment different from other treatments for postpartum mental health?

The CARE Parenting Program is unique because it involves both mothers and their infants in the treatment process, focusing on improving maternal-infant attachment and mental health through a collaborative group intervention, unlike most programs that only include the mother.26789

What is the purpose of this trial?

This trial is testing a group therapy program called CARE for parents with postpartum depression or anxiety. The program helps parents understand their own and their baby's thoughts and feelings to improve mental health and reduce stress. The study targets parents with infants aged 3 to 12 months who are receiving care at Montefiore Medical Center.

Research Team

AZ

Amanda Zayde, Psy.D.

Principal Investigator

Montefiore Medical Center/Albert Einstein College of Medicine

Eligibility Criteria

This trial is for postpartum parents who have given birth within the last 3-12 months, are English-speaking, and are currently receiving care at Montefiore Medical Center. It's aimed at those experiencing moderate to high levels of depression or anxiety after childbirth. Parents already in a CARE group or another parenting program, with severe mental health issues needing intense treatment, or current psychosis/mania can't participate.

Inclusion Criteria

English-speaking
I am a parent of a baby aged 3-12 months.
Receiving postpartum OB/GYN or mental health services at Montefiore Medical Center
See 1 more

Exclusion Criteria

You are currently experiencing severe mental health symptoms like hallucinations or extreme mood swings.
You have mental health, memory, or substance abuse problems that require more intense care than just visiting a doctor, such as being in the hospital.
Prior participation in a Connecting and Reflecting Experience (CARE) group at any time
See 1 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants engage in a 12-session CARE parenting group therapy program

15 weeks
12 sessions (in-person or virtual)

Follow-up

Participants are monitored for changes in mental health, parenting stress, and parent-infant bonding after treatment

4 weeks

Treatment Details

Interventions

  • Connecting and Reflecting Experience (CARE) Program
Trial Overview The study tests the Connecting and Reflecting Experience (CARE) Program—a group therapy designed to improve mental health, reduce parenting stress, and strengthen parent-infant relationships among postpartum parents with mood/anxiety disorders. Participants will attend 12 sessions and complete surveys to assess the program's impact on their well-being.
Participant Groups
1Treatment groups
Experimental Treatment
Group I: Connecting and Reflecting Experience (CARE) ProgramExperimental Treatment1 Intervention
Participants will enroll in a 12-session CARE parenting group therapy.

Connecting and Reflecting Experience (CARE) Program is already approved in United States for the following indications:

🇺🇸
Approved in United States as Connecting and Reflecting Experience (CARE) Program for:
  • Postpartum mood and/or anxiety disorders (PMADs)
  • Parenting stress
  • Improving parent-infant relationships

Find a Clinic Near You

Who Is Running the Clinical Trial?

Montefiore Medical Center

Lead Sponsor

Trials
468
Recruited
599,000+

American Psychological Foundation

Collaborator

Trials
20
Recruited
2,200+

Findings from Research

A new outpatient psychotherapeutic treatment program has been developed specifically for mothers experiencing acute postpartum mental illness, addressing their unique needs during the perinatal period.
Empirical results suggest that this outpatient program is an effective alternative to hospitalization, allowing mothers to receive necessary treatment without being separated from their children.
Outpatient psychotherapy for mothers--a new treatment.Kersting, A., Fisch, S., Arolt, V.[2018]
In a 6-month project involving 273 mothers, a screening protocol for postpartum depression (PPD) was successfully implemented, achieving an 83.5% screening rate during well-child visits.
Of the mothers who screened positive for PPD, 73.1% were referred to mental health services, and 63.2% attended their referral, demonstrating effective follow-up and support for those in need.
Multilingual Postpartum Depression Screening in Pediatric Community Health Clinics.Cohen, M., Stephens, CTD., Zaheer, A., et al.[2022]
The study aims to compare the effectiveness of two interventions for perinatal depression: the Massachusetts Child Psychiatry Access Program (MCPAP) for Moms and the more comprehensive PRogram In Support of Moms (PRISM), which includes MCPAP plus additional support.
This research involves a cluster randomized controlled trial with ongoing recruitment of participants, who will be followed for up to 13 months postpartum, allowing for a thorough examination of depression symptom changes and treatment engagement across different stages of pregnancy and postpartum.
The PRogram In Support of Moms (PRISM): study protocol for a cluster randomized controlled trial of two active interventions addressing perinatal depression in obstetric settings.Moore Simas, TA., Brenckle, L., Sankaran, P., et al.[2023]

References

Outpatient psychotherapy for mothers--a new treatment. [2018]
Multilingual Postpartum Depression Screening in Pediatric Community Health Clinics. [2022]
The PRogram In Support of Moms (PRISM): study protocol for a cluster randomized controlled trial of two active interventions addressing perinatal depression in obstetric settings. [2023]
[Strengthening Attachment Competencies in Parents with Mental Illness: Adaptation and Pilot Testing of the Mentalization-Based Lighthouse Parenting Program]. [2019]
Innovative psycho-educational program to prevent common postpartum mental disorders in primiparous women: a before and after controlled study. [2023]
Evaluation of a collaborative group intervention for mothers with moderate to severe perinatal mental illness and their infants in Australia. [2021]
Integrated mental health care in a multidisciplinary maternal and child health service in the community: the findings from the Suzaka trial. [2020]
A psychiatric mother-baby day hospital for pregnant and postpartum women. [2016]
State mandates regarding postpartum depression. [2015]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security